Growth Metrics

Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2020 - 2025)

Historic Non-Current Deferred Tax Liability for Gilead Sciences (GILD) over the last 10 years, with Q3 2025 value amounting to $597.0 million.

  • Gilead Sciences' Non-Current Deferred Tax Liability fell 2481.11% to $597.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $597.0 million, marking a year-over-year decrease of 2481.11%. This contributed to the annual value of $724.0 million for FY2024, which is 8780.94% down from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Non-Current Deferred Tax Liability is $597.0 million, which was down 2481.11% from $652.0 million recorded in Q2 2025.
  • Gilead Sciences' Non-Current Deferred Tax Liability's 5-year high stood at $7.1 billion during Q4 2021, with a 5-year trough of $597.0 million in Q3 2025.
  • For the 5-year period, Gilead Sciences' Non-Current Deferred Tax Liability averaged around $2.9 billion, with its median value being $2.4 billion (2023).
  • In the last 5 years, Gilead Sciences' Non-Current Deferred Tax Liability soared by 861.23% in 2021 and then tumbled by 8780.94% in 2024.
  • Over the past 5 years, Gilead Sciences' Non-Current Deferred Tax Liability (Quarter) stood at $7.1 billion in 2021, then decreased by 14.23% to $6.1 billion in 2022, then fell by 2.99% to $5.9 billion in 2023, then plummeted by 87.81% to $724.0 million in 2024, then decreased by 17.54% to $597.0 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $597.0 million for Q3 2025, versus $652.0 million for Q2 2025 and $709.0 million for Q1 2025.